Drug Shows Promise in Advanced Prostate Cancer When Used Before Chemotherapy
The drug Xtandi, already on the market for post-chemotherapy use, could open a new front in its competition with Johnson & Johnson's Zytiga.
Drug Shows Promise in Advanced Prostate Cancer When Used Before Chemotherapy
The drug Xtandi, already on the market for post-chemotherapy use, could open a new front in its competition with Johnson & Johnson's Zytiga.
No comments:
Post a Comment